Back to top
more

Rite Aid Corporation (RAD)

(Delayed Data from NYSE)

$8.77 USD

8.77
1,437,900

-0.03 (-0.34%)

Updated May 3, 2019 04:02 PM ET

After-Market: $8.75 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Rite Aid (RAD) Q3 Loss Narrower Than Expected, Revenues Down

Rite Aid's (RAD) Q3 results reflect the impacts of drab demand in flu immunizations and COVID-19 vaccines. Also, management updates its fiscal 2023 view.

Rite Aid (RAD) Reports Q3 Loss, Tops Revenue Estimates

Rite Aid (RAD) delivered earnings and revenue surprises of 56.25% and 2.46%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?

Here's How Rite Aid (RAD) is Placed Just Ahead of Q3 Earnings

Higher non-COVID prescriptions, strength in PBM and the expansion of delivery services are likely to Rite Aid's (RAD) Q3 results amid sluggishness in the Retail Pharmacy and Pharmacy Services segments.

Costco (COST) Lags Q1 Earnings and Revenue Estimates

Costco (COST) delivered earnings and revenue surprises of -1.27% and 0.42%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?

Rite Aid (RAD) Dips More Than Broader Markets: What You Should Know

Rite Aid (RAD) closed at $5.16 in the latest trading session, marking a -1.34% move from the prior day.

Rite Aid (RAD) Stock Sinks As Market Gains: What You Should Know

Rite Aid (RAD) closed the most recent trading day at $5.25, moving -0.94% from the previous trading session.

Rite Aid (RAD) Dips More Than Broader Markets: What You Should Know

Rite Aid (RAD) closed at $5.91 in the latest trading session, marking a -1.83% move from the prior day.

Rite Aid (RAD) Stock Sinks As Market Gains: What You Should Know

Rite Aid (RAD) closed the most recent trading day at $5.49, moving -0.54% from the previous trading session.

Rite Aid (RAD) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Rite Aid (RAD) closed at $5.14, marking a -1.53% move from the previous day.

Online Strength to Drive Rite Aid (RAD) Amid Supply-Chain Woes

Rite Aid (RAD) remains well-placed on online strength, increased non-COVID prescriptions and cost initiatives despite muted COVID-19 testing and vaccine demand, and supply-chain issues.

Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance, Rite Aid and Amazon's

CVS Health, Walgreens Boots Alliance, Rite Aid and Amazon's are part of Zacks Industry Outlook article.

Urmimala Biswas headshot

3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Challenges

The Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain from the growing demand for digital healthcare support. However, reimbursement challenges are hurting overall industry health.

Rite Aid (RAD) Q2 Loss Wider Than Expected, Revenues Beat

Rite Aid (RAD) posts lower Q2 revenues from the year-ago fiscal quarter's level due to sluggishness in both the Retail Pharmacy and Pharmacy Services segments.

Rite Aid (RAD) Reports Q2 Loss, Tops Revenue Estimates

Rite Aid (RAD) delivered earnings and revenue surprises of -36.96% and 0.66%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?

Factors Likely to Decide Rite Aid's (RAD) Fate in Q2 Earnings

Rite Aid's (RAD) Q2 performance is likely to have been hurt by low COVID vaccine and testing demand. Strength in PBM, digital expansion and higher non-COVID prescriptions are expected to have aided.

Tilly's (TLYS) Misses Q2 Earnings and Revenue Estimates

Tilly's (TLYS) delivered earnings and revenue surprises of -18.75% and 1.45%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?

Rite Aid (RAD) Moves 7.9% Higher: Will This Strength Last?

Rite Aid (RAD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Rite Aid (RAD) Q1 Loss Narrower Than Expected, Revenues Beat

Rite Aid's (RAD) Q1 results gain from higher sales of non-COVID-19 prescriptions and continued momentum at Elixir. Management raises its revenue guidance for fiscal 2023.

Rite Aid (RAD) Reports Q1 Loss, Tops Revenue Estimates

Rite Aid (RAD) delivered earnings and revenue surprises of 14.29% and 5%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?

What is Likely to Drive Rite Aid's (RAD) Earnings in Q1?

Strong underlying business and robust digital and retail growth are expected to aid Rite Aid (RAD) in Q1. Its Retail Pharmacy segment is likely to be a key contributor despite supply headwinds.

Signet (SIG) Q1 Earnings and Revenues Beat Estimates

Signet (SIG) delivered earnings and revenue surprises of 24.89% and 1.62%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?

Vera Bradley (VRA) Reports Q1 Loss, Lags Revenue Estimates

Vera Bradley (VRA) delivered earnings and revenue surprises of -18.75% and 11.69%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?

Cracker Barrel Old Country Store (CBRL) Beats Q3 Earnings Estimates

Cracker Barrel (CBRL) delivered earnings and revenue surprises of 6.61% and 0.03%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?

Implied Volatility Surging for Rite Aid (RAD) Stock Options

Investors need to pay close attention to Rite Aid (RAD) stock based on the movements in the options market lately.

Rite Aid (RAD) Q4 Loss Wider Than Expected, Revenues Beat

Rite Aid's (RAD) Q4 results gains from growth in the Retail Pharmacy unit. Also, management issued an upbeat fiscal 2023 view.